A mouse colitis study demonstrated that CCL21 suppression could decrease damage induced by ulcerative colitis (Zhang et al., 2014), suggesting that CCL21 might be a therapeutic target for UC treatment. The gene discussed is CCL21; the disease is ulcerative colitis.